As the world learns to live with COVID-19, one positive is the emergence of gene-sequencing technologies. Researchers now have a tool capable of tracking the spread of contagion throughout the biologic environment, in real time, thus offering the prospect of early, more targeted health interventions that prevent illness and save lives. Deconstructing the genome of a pathogen through human sample sequencing has led to a better understanding of viral transmissibility as well as the intensity of emerging mutations.
That is all to the good. But science alone is insufficient to ensure gene sequencing delivers actionable results at the front line of clinical care, where data and evidence meet...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?